The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
Grepafloxacin: microbiological properties
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
The changing epidemiology of severe infections in the ICU
Herpes zoster in non-hospitalized children
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum  Ronald N. Jones, M.D., Mary.
Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995  Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,
Inducible β-lactamase-mediated resistance to third-generation cephalosporins  Ronald N Jones, Fernando Baquero, Gaetano Privitera, Matsuhisa Inoue, Bernd.
Hydatid disease Clinical Microbiology and Infection
Didier Guillemot, Claude Carbon  Clinical Microbiology and Infection 
Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media  Fernando Baquero, Rafael Cantón, Fernando.
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program  M.
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
D.E. Low  Clinical Microbiology and Infection 
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage  Ron Dagan, Drora Fraser, Noga Givon, Pablo.
Training for the infectious diseases speciality in Norway
Cephalosporins: a pharmacological update
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
In vitro selective concentrations of cefepime and ceftazidime for AmpC β-lactamase hyperproducer Enterobacter cloacae variants  Maria-Cristina Negri,
Ventilator-associated pneumonia—Understanding epidemiology and pathogenesis to guide prevention and empiric therapy  Patrick Francioli, Jean Chastre,
Sepsis and neutropenia induced by clozapine
Antibiotic usage and the incidence of resistance
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
André Bryskier  Clinical Microbiology and Infection 
Levofloxacin in the treatment of ventilator-associated pneumonia
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
MIC distribution and inoculum effect of LY333328: a study of vancomycin-susceptible and VanA-type and VanC-type enterococci obtained from intensive care.
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
Antimicrobial susceptibility of non-Bacteroides fragilis group anaerobic Gram-negative bacilli in Europe  Anna King, Julie Downes, Carl-Erik Nord, Ian.
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France  Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Community-acquired pneumonia: epidemiologic and clinical consideration
Grepafloxacin: pharmacokinetics and tissue penetration
Reducing antibiotic use in influenza: challenges and rewards
Definition of the Clinical Antibacterial Spectrum of Activity
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
Overview of cefixime use in community-acquired infections
The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model  Alasdair P. MacGowan,
Sanford Chodosh  Clinical Microbiology and Infection 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Modification of prescribers’ behavior: the Icelandic approach
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Fernando Baquero, John F
The future of diagnostic bacteriology
Presentation transcript:

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci  Keith Klugman, Fred Goldstein, Shigeru Kohno, Fernando Baquero  Clinical Microbiology and Infection  Volume 3, Pages S48-S60 (April 1997) DOI: 10.1111/j.1469-0691.1997.tb00646.x Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 World-wide frequency of isolation of penicillin-resistant pneumococci (MIC > 0.12 mg/L, intermediate and high-level penicillin-resistant strains). Clinical Microbiology and Infection 1997 3, S48-S60DOI: (10.1111/j.1469-0691.1997.tb00646.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Effect of increasing the MIC values of penicillin on the 50% effective dose (ED50) in a S. pneumoniae peritonitis mouse model following penicillin treatment. From Knudsen et al. 50. With permission of Am Soc Microbiol J Div. Clinical Microbiology and Infection 1997 3, S48-S60DOI: (10.1111/j.1469-0691.1997.tb00646.x) Copyright © 1997 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.